Recently Beta Bionics, the makers of the iLet artificial pancreas, reached a significant milestone: raising $1 million through online public fundraising. It is no longer a question of if an artificial pancreas will exist, but of when it will become commercially available. With every major insulin pump company working in this area, along with many startups, patients will not just have one system, but several they can chose from.
Read More »The Use of Technology in Medical Practice
How do consumers and HCPs feel about new technologies and their impact on our health system?
Read More »How Will CGM’s Success Impact Conventional Glucose Monitors?
Guest Post by David Kliff, Diabetic Investor
The FDA approved Dexcom’s request for a non-adjunctive claim this week. It looks like a bad situation for conventional glucose monitors, and believe it or not is about to get worse. Here’s why.
Will 2017 Bring Us the First Artificial Pancreas for Type 1 Diabetes?
System shows significant improvement in HbA1c compared to current best therapy available.
Read More »FREEDOM-2 Trial Results for ITCA 650: Breakthrough New Product Announced
First a little explanation about the new unique product with its own delivery system. This is not only a medication but also a matchstick-sized osmotic mini pump that is the size of a match and is placed just beneath the skin to deliver a continuous and consistent flow of medication for a year.
Read More »The AspireAssist ®
A new weight loss device, AspireAssist, offers a novel approach to cutting calories: draining them from the stomach before they are fully digested. The AspireAssist® system consists of a thin tube implanted in the stomach, connecting to an outside port on the skin of the belly.
Read More »New Implantable CGM Receives Approval
Senseonics' Eversense™ 90-day implantable CGM approved in Europe.
Read More »CGMS Update
Innovation and improvement in CGMS technology has risen dramatically over the last 2 years, paving the way for the artificial pancreas.
Read More »Fact: Downloading of Data From Our Apps, Meters and CGM’s is Great. But How Do We Use It?
According to Jenise Wong, MD, PhD, of the University of California San Francisco, who reported the results at an oral session at the joint meeting of the Endocrine Society and the International Congress on Endocrinology, “We need to really equip patients with better tools and education on how to use their data.” David Kliff responds: Now some would argue that this is why IDM is needed, as it not only collects and transmits data, but it provides for an easy interaction between the patient and their healthcare team; that it’s the healthcare team that’s doing all the data analytics; that all the patient needs to do is collect the data; and that this focus on data can actually make a patient tune out even when they are getting good advice. Here is a perfect example of what we are talking about. Read more
Read More »Dr. Larry Hirsch, Part 4: Infusion Set Comparison
Diabetes in Control publisher Steve Freed met with Dr. Larry Hirsch, Vice President of Global Medical Affairs for the Diabetes Care Business at BD at the 2015 ADA Sessions in Boston. In this final installment, Dr. Hirsch summarizes his ADA 2015 presentation, including a comparison of the BD infusion set to the current popular model, and images showing the fluid within infusion sets as captured by MRI and ultrasound.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.